Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$223.92 - $287.77 $5.6 Million - $7.19 Million
-25,000 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$259.0 - $414.71 $3.89 Million - $6.22 Million
-15,000 Reduced 37.5%
25,000 $8.66 Million
Q4 2020

Feb 16, 2021

BUY
$236.26 - $355.63 $1.89 Million - $2.85 Million
8,000 Added 25.0%
40,000 $9.79 Million
Q2 2020

Aug 14, 2020

BUY
$258.66 - $342.55 $517,320 - $685,100
2,000 Added 6.67%
32,000 $8.56 Million
Q1 2020

May 15, 2020

BUY
$268.85 - $341.04 $8.07 Million - $10.2 Million
30,000 New
30,000 $9.49 Million
Q4 2019

Feb 13, 2020

SELL
$220.06 - $304.07 $7.7 Million - $10.6 Million
-35,000 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$217.44 - $243.88 $3.26 Million - $3.66 Million
15,000 Added 75.0%
35,000 $8.15 Million
Q2 2019

Aug 14, 2019

BUY
$219.29 - $241.72 $1.1 Million - $1.21 Million
5,000 Added 33.33%
20,000 $4.68 Million
Q1 2019

May 15, 2019

BUY
$216.71 - $338.96 $3.25 Million - $5.08 Million
15,000 New
15,000 $3.55 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $20.3B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Sprott Inc. Portfolio

Follow Sprott Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sprott Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sprott Inc. with notifications on news.